作者
Matthew Royle

Matthew Royle, Ph.D.

合伙人

Read More
作者
Matthew Royle

Matthew Royle, Ph.D.

合伙人

Read More

2019年12月17日 |

Biosimilars – The economics of biosimilars: Market access, pricing and legal considerations

The fourth and final session of our 2019 webinar series focuses on the economic and legal factors affecting biosimilar pricing and uptake.

NERA Economic Consulting experts David Blackburn, Ph.D. and Rasmus Jørgensen, Ph.D. provide their unique insights in the US and European biosimilar markets, including a discussion of key similarities and differences in pricing and market access in the two regions.

Willkie partner Heather M. Schneider and Taylor Wessing partner Matthew Royle discuss key legal aspects of biosimilar regulation that may be affecting pricing and market access.

This session also provides a brief update on key biosimilar decisions, legislation and events from 2019.

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

centrifuge-machine
酒店与休闲

Dissecting the Regeneron v Kymab mouse case – what it says and its impact on patents

2020年7月27日
QUICK READ

作者

点击此处了解更多
酒店与休闲

Recent legislative developments affecting biologics and biosimilars

2019年5月30日

作者

点击此处了解更多

相关活动